Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 118 articles: HTML format Text format

Single Articles

May 2018
1. VALLANCE AE, van der Meulen J, Kuryba A, Braun M, et al
   Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
   Eur J Surg Oncol. 2018 May 26. pii: S0748-7983(18)31078.
   PubMed     Text format     Abstract available
   
   
   
2. CLOYD JM, Mizuno T, Vauthey JN
   Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
   Eur J Surg Oncol. 2018 May 18. pii: S0748-7983(18)31070.
   PubMed     Text format    
   
   
   
3. TRAUTMANN F, Reissfelder C, Pecqueux M, Weitz J, et al
   Evidence-based quality standards improve prognosis in colon cancer care.
   Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31067.
   PubMed     Text format     Abstract available
   
   
   
4. CRISTOBAL I, Torrejon B, Santos A, Luque M, et al
   Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
   Eur J Surg Oncol. 2018 May 9. pii: S0748-7983(18)31027.
   PubMed     Text format    
   
   
   April 2018
5. MINNELLA EM, Carli F
   Prehabilitation and functional recovery for colorectal cancer patients.
   Eur J Surg Oncol. 2018 Apr 30. pii: S0748-7983(18)31022.
   PubMed     Text format     Abstract available
   
   
   
6. DEGIULI M, Arolfo S, Evangelista A, Lorenzon L, et al
   Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network"(SICO-CCN) multicentre collaborative study.
   Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31012.
   PubMed     Text format     Abstract available
   
   
   
7. BROUWER NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, et al
   Clinical lymph node staging in colorectal cancer; a flip of the coin?
   Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31013.
   PubMed     Text format     Abstract available
   
   
   
8. FALCAO D, Alexandrino H, Caetano Oliveira R, Martins J, et al
   Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
   Eur J Surg Oncol. 2018 Apr 11. pii: S0748-7983(18)30992.
   PubMed     Text format     Abstract available
   
   
   
9. SHIDA D, Ochiai H, Tsukamoto S, Kanemitsu Y, et al
   Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses.
   Eur J Surg Oncol. 2018 Apr 5. pii: S0748-7983(18)30991.
   PubMed     Text format     Abstract available
   
   
   
10. ITO M, Kobayashi A, Fujita S, Mizusawa J, et al
    Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG02
    Eur J Surg Oncol. 2018;44:463-468.
    PubMed     Text format     Abstract available
    
    
    
11. LORENZON L, Biondi A, Carus T, Dziki A, et al
    Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus-based position paper.
    Eur J Surg Oncol. 2018;44:469-483.
    PubMed     Text format     Abstract available
    
    
    
12. FIGUEIREDO N, Panteleimonitis S, Popeskou S, Cunha JF, et al
    Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Eur J Surg Oncol. 2018;44:484-489.
    PubMed     Text format     Abstract available
    
    
    
13. HUTTNER FJ, Warschkow R, Schmied BM, Diener MK, et al
    Prognostic impact of anastomotic leakage after elective colon resection for cancer - A propensity score matched analysis of 628 patients.
    Eur J Surg Oncol. 2018;44:456-462.
    PubMed     Text format     Abstract available
    
    
    March 2018
14. ZABALETA J, Iida T, Falcoz PE, Salah S, et al
    Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30957.
    PubMed     Text format     Abstract available
    
    
    February 2018
15. CASHIN PH, Mahteme H, Syk I, Frodin JE, et al
    Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases.
    Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30672.
    PubMed     Text format     Abstract available
    
    
    
16. SHIM JR, Lee SD, Han SS, Lee SJ, et al
    Prognostic significance of (18)F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30292.
    PubMed     Text format     Abstract available
    
    
    
17. FURUKI H, Yamada T, Takahashi G, Iwai T, et al
    Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30273.
    PubMed     Text format     Abstract available
    
    
    
18. STIJNS RCH, Tromp MR, Hugen N, de Wilt JHW, et al
    Advances in organ preserving strategies in rectal cancer patients.
    Eur J Surg Oncol. 2018;44:209-219.
    PubMed     Text format     Abstract available
    
    
    
19. PEREZ D, Melling N, Biebl M, Reeh M, et al
    Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases.
    Eur J Surg Oncol. 2018;44:237-242.
    PubMed     Text format     Abstract available
    
    
    
20. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
    Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
    Eur J Surg Oncol. 2018;44:228-236.
    PubMed     Text format     Abstract available
    
    
    January 2018
21. OKAMURA R, Hida K, Nishizaki D, Sugihara K, et al
    Proposal of a stage-specific surveillance strategy for colorectal cancer patients: A retrospective analysis of Japanese large cohort.
    Eur J Surg Oncol. 2018 Jan 31. pii: S0748-7983(18)30116.
    PubMed     Text format     Abstract available
    
    
    
22. SHEN Z, Lin Y, Ye Y, Jiang K, et al
    The development and validation of a novel model for predicting surgical complications in colorectal cancer of elderly patients: Results from 1008 cases.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30034.
    PubMed     Text format     Abstract available
    
    
    
23. WESTBERG K, Palmer G, Hjern F, Johansson H, et al
    Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Eur J Surg Oncol. 2018;44:100-107.
    PubMed     Text format     Abstract available
    
    
    
24. SAO JULIAO GP, Habr-Gama A, Vailati BB, Aguilar PB, et al
    Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    Eur J Surg Oncol. 2018;44:93-99.
    PubMed     Text format     Abstract available
    
    
    
25. OMICHI K, Shindoh J, Cloyd JM, Mizuno T, et al
    Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Eur J Surg Oncol. 2018;44:122-129.
    PubMed     Text format     Abstract available
    
    
    
26. STIFT J, Graf A, Schwarz C, Tamandl D, et al
    Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:139-147.
    PubMed     Text format     Abstract available
    
    
    
27. LINTER KAPISINSKA M, Hovorkova E, Zavalova V, Subrt Z, et al
    Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers.
    Eur J Surg Oncol. 2018;44:87-92.
    PubMed     Text format     Abstract available
    
    
    
28. DUPRE A, Malik HZ, Jones RP, Diaz-Nieto R, et al
    Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:80-86.
    PubMed     Text format     Abstract available
    
    
    
29. SUTTON PA, Jithesh PV, Jones RP, Evans JP, et al
    Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
    Eur J Surg Oncol. 2018;44:115-121.
    PubMed     Text format     Abstract available
    
    
    
30. JONES HJS, Cunningham C, Nicholson GA, Hompes R, et al
    Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
    Eur J Surg Oncol. 2018;44:15-23.
    PubMed     Text format     Abstract available
    
    
    
31. HUISKENS J, Olthof PB, van der Stok EP, Bais T, et al
    Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
    Eur J Surg Oncol. 2018;44:108-114.
    PubMed     Text format     Abstract available
    
    
    December 2017
32. DESJARDIN M, Desolneux G, Brouste V, Degrandi O, et al
    Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.
    Eur J Surg Oncol. 2017;43:2285-2291.
    PubMed     Text format     Abstract available
    
    
    
33. CHAPELLE T, Op de Beeck B, Driessen A, Roeyen G, et al
    Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores.
    Eur J Surg Oncol. 2017;43:2277-2284.
    PubMed     Text format     Abstract available
    
    
    November 2017
34. REHA J, Mukkamalla SKR, Rathore R, Somasundar PS, et al
    Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30966.
    PubMed     Text format     Abstract available
    
    
    
35. VAN EDEN WJ, Kok NFM, Woensdregt K, Huitema ADR, et al
    Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    Eur J Surg Oncol. 2017 Nov 15. pii: S0748-7983(17)30956.
    PubMed     Text format     Abstract available
    
    
    
36. OFFERMANS T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, et al
    Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.
    Eur J Surg Oncol. 2017;43:2105-2111.
    PubMed     Text format     Abstract available
    
    
    
37. YOUNG CJ, Zahid A, Choy I, Thompson JF, et al
    Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
    Eur J Surg Oncol. 2017;43:2163-2169.
    PubMed     Text format     Abstract available
    
    
    
38. SIDDIQUI MRS, Shanmuganandan AP, Rasheed S, Tekkis P, et al
    An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines.
    Eur J Surg Oncol. 2017;43:2093-2104.
    PubMed     Text format     Abstract available
    
    
    
39. GASH KJ, Baser O, Kiran RP
    Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes.
    Eur J Surg Oncol. 2017;43:2052-2059.
    PubMed     Text format     Abstract available
    
    
    
40. HELDENS AFJM, Bongers BC, Lenssen AF, Stassen LPS, et al
    The association between performance parameters of physical fitness and postoperative outcomes in patients undergoing colorectal surgery: An evaluation of care data.
    Eur J Surg Oncol. 2017;43:2084-2092.
    PubMed     Text format     Abstract available
    
    
    
41. LEE SH, Lee JL, Kim CW, Lee HI, et al
    Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:2076-2083.
    PubMed     Text format     Abstract available
    
    
    
42. PETZ W, Ribero D, Bertani E, Borin S, et al
    Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
    Eur J Surg Oncol. 2017;43:2060-2066.
    PubMed     Text format     Abstract available
    
    
    October 2017
43. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
    Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Eur J Surg Oncol. 2017;43:1901-1907.
    PubMed     Text format     Abstract available
    
    
    
44. SUN Y, Xu Z, Lin H, Lu X, et al
    Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Eur J Surg Oncol. 2017;43:1828-1834.
    PubMed     Text format     Abstract available
    
    
    
45. JONKER FHW, Hagemans JAW, Verhoef C, Burger JWA, et al
    The impact of hospital volume on perioperative outcomes of rectal cancer.
    Eur J Surg Oncol. 2017;43:1894-1900.
    PubMed     Text format     Abstract available
    
    
    
46. KVERNENG HULTBERG D, Angenete E, Lydrup ML, Rutegard J, et al
    Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer.
    Eur J Surg Oncol. 2017;43:1908-1914.
    PubMed     Text format     Abstract available
    
    
    
47. SOLON JG, O'Neill M, Chang KH, Deady S, et al
    An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Eur J Surg Oncol. 2017;43:1924-1931.
    PubMed     Text format     Abstract available
    
    
    September 2017
48. DUWE G, Knitter S, Pesthy S, Beierle AS, et al
    Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
    Eur J Surg Oncol. 2017;43:1668-1681.
    PubMed     Text format     Abstract available
    
    
    August 2017
49. BIN TRAIKI TA, Fisher OM, Valle SJ, Parikh RN, et al
    Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
    Eur J Surg Oncol. 2017 Aug 31. pii: S0748-7983(17)30639.
    PubMed     Text format     Abstract available
    
    
    
50. CURRIE AC, Brigic A, Thomas-Gibson S, Suzuki N, et al
    A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
    Eur J Surg Oncol. 2017 Aug 23. pii: S0748-7983(17)30643.
    PubMed     Text format     Abstract available
    
    
    
51. POSTON G, Adam R, Xu J, Byrne B, et al
    The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30605.
    PubMed     Text format     Abstract available
    
    
    
52. RIZZO G, Zaccone G, Magnocavallo M, Mattana C, et al
    Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.
    Eur J Surg Oncol. 2017;43:1488-1493.
    PubMed     Text format     Abstract available
    
    
    
53. LORENZON L, Parini D, Rega D, Mellano A, et al
    Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO).
    Eur J Surg Oncol. 2017;43:1472-1480.
    PubMed     Text format     Abstract available
    
    
    
54. HANDGRAAF HJM, Boogerd LSF, Hoppener DJ, Peloso A, et al
    Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis.
    Eur J Surg Oncol. 2017;43:1463-1471.
    PubMed     Text format     Abstract available
    
    
    
55. ZHANG Y, Sun Y, Xu Z, Chi P, et al
    Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
    Eur J Surg Oncol. 2017;43:1440-1446.
    PubMed     Text format     Abstract available
    
    
    July 2017
56. DE FELICE F, Magnante AL, Musio D, Ciolina M, et al
    Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Eur J Surg Oncol. 2017;43:1324-1329.
    PubMed     Text format     Abstract available
    
    
    
57. BAUKLOH JK, Reeh M, Spinoglio G, Corratti A, et al
    Evaluation of the robotic approach concerning pitfalls in rectal surgery.
    Eur J Surg Oncol. 2017;43:1304-1311.
    PubMed     Text format     Abstract available
    
    
    June 2017
58. KARIM S, Nanji S, Brennan K, Pramesh CS, et al
    Chemotherapy for resected colorectal cancer pulmonary metastases: Utilization and outcomes in routine clinical practice.
    Eur J Surg Oncol. 2017 Jun 1. pii: S0748-7983(17)30480.
    PubMed     Text format     Abstract available
    
    
    
59. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    PubMed     Text format     Abstract available
    
    
    
60. DELHORME JB, Sattler L, Severac F, Triki E, et al
    Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?
    Eur J Surg Oncol. 2017;43:1095-1101.
    PubMed     Text format     Abstract available
    
    
    May 2017
61. VAN DEN HEIJKANT F, Vermeer TA, Vrijhof EJEJ, Nieuwenhuijzen GAP, et al
    Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome.
    Eur J Surg Oncol. 2017 May 26. pii: S0748-7983(17)30501.
    PubMed     Text format     Abstract available
    
    
    
62. LIBERALE G, Bourgeois P, Larsimont D, Moreau M, et al
    Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review.
    Eur J Surg Oncol. 2017 May 8. pii: S0748-7983(17)30457.
    PubMed     Text format     Abstract available
    
    
    
63. FLEMMING JA, Nanji S, Wei X, Webber C, et al
    Association between the time to surgery and survival among patients with colon cancer: A population-based study.
    Eur J Surg Oncol. 2017 May 6. pii: S0748-7983(17)30456.
    PubMed     Text format     Abstract available
    
    
    
64. SLOOTHAAK DAM, van der Linden RLA, van de Velde CJH, Bemelman WA, et al
    Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: The correlation between micrometastasis and disease recurrence.
    Eur J Surg Oncol. 2017 May 5. pii: S0748-7983(17)30454.
    PubMed     Text format     Abstract available
    
    
    
65. ASKLID D, Segelman J, Gedda C, Hjern F, et al
    The impact of perioperative fluid therapy on short-term outcomes and 5-year survival among patients undergoing colorectal cancer surgery - A prospective cohort study within an ERAS protocol.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30445.
    PubMed     Text format     Abstract available
    
    
    
66. JONES RP, Brudvik KW, Franklin JM, Poston GJ, et al
    Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.
    Eur J Surg Oncol. 2017;43:875-883.
    PubMed     Text format     Abstract available
    
    
    April 2017
67. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    PubMed     Text format     Abstract available
    
    
    
68. FRUHLING P, Nilsson A, Duraj F, Haglund U, et al
    Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Eur J Surg Oncol. 2017;43:751-757.
    PubMed     Text format     Abstract available
    
    
    
69. FRUHLING P
    Reply to: Microwave thermosphere ablation in the multimodal management of colorectal cancer liver metastasis'.
    Eur J Surg Oncol. 2017 Apr 1. pii: S0748-7983(17)30434.
    PubMed     Text format    
    
    
    March 2017
70. PIARDI T, Chetboun M, Sommacale D, Kianmanesh R, et al
    Microwave Thermosphere ablation in the multimodal management of colorectal cancer liver metastasis.
    Eur J Surg Oncol. 2017 Mar 24. pii: S0748-7983(17)30429.
    PubMed     Text format    
    
    
    
71. PUCCIARELLI S, Zorzi M, Gennaro N, Gagliardi G, et al
    In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: A national population-based study.
    Eur J Surg Oncol. 2017 Mar 16. pii: S0748-7983(17)30369.
    PubMed     Text format     Abstract available
    
    
    
72. GIETELINK L, Wouters MW, Marijnen CA, van Groningen J, et al
    Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
    Eur J Surg Oncol. 2017 Mar 10. pii: S0748-7983(17)30366.
    PubMed     Text format     Abstract available
    
    
    February 2017
73. FLOODEEN H, Hallbook O, Hagberg LA, Matthiessen P, et al
    Costs and resource use following defunctioning stoma in low anterior resection for cancer - A long-term analysis of a randomized multicenter trial.
    Eur J Surg Oncol. 2017;43:330-336.
    PubMed     Text format     Abstract available
    
    
    
74. ARROYAVE MC, DeLacy FB, Lacy AM
    Transanal total mesorectal excision (TaTME) for rectal cancer: Step by step description of the surgical technique for a two-teams approach.
    Eur J Surg Oncol. 2017;43:502-505.
    PubMed     Text format     Abstract available
    
    
    January 2017
75. YAMASHITA S, Odisio BC, Huang SY, Kopetz SE, et al
    Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30057.
    PubMed     Text format     Abstract available
    
    
    
76. DENOST Q, Kontovounisios C, Rasheed S, Chevalier R, et al
    Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Eur J Surg Oncol. 2017;43:92-99.
    PubMed     Text format     Abstract available
    
    
    
77. SUN Y, Chi P, Lin H, Lu X, et al
    Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.
    Eur J Surg Oncol. 2017;43:85-91.
    PubMed     Text format     Abstract available
    
    
    
78. OLTHOF PB, Huiskens J, Schulte NR, Wicherts DA, et al
    Hepatic vascular inflow occlusion is associated with reduced disease free survival following resection of colorectal liver metastases.
    Eur J Surg Oncol. 2017;43:100-106.
    PubMed     Text format     Abstract available
    
    
    
79. HOLMAN FA, Bosman SJ, Haddock MG, Gunderson LL, et al
    Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
    Eur J Surg Oncol. 2017;43:107-117.
    PubMed     Text format     Abstract available
    
    
    December 2016
80. NANJI S, Tsang ME, Wei X, Booth CM, et al
    Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases.
    Eur J Surg Oncol. 2016 Dec 13. pii: S0748-7983(16)31035.
    PubMed     Text format     Abstract available
    
    
    
81. XU W, Xu Z, Cheng H, Ying J, et al
    Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Eur J Surg Oncol. 2016;42:1841-1850.
    PubMed     Text format     Abstract available
    
    
    
82. MANCHON-WALSH P, Aliste L, Espinas JA, Prades J, et al
    Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
    Eur J Surg Oncol. 2016;42:1873-1880.
    PubMed     Text format     Abstract available
    
    
    November 2016
83. MONASTYRSKA E, Hagner W, Jankowski M, Glowacka I, et al
    Prospective assessment of the quality of life in patients treated surgically for rectal cancer with lower anterior resection and abdominoperineal resection.
    Eur J Surg Oncol. 2016;42:1647-1653.
    PubMed     Text format     Abstract available
    
    
    
84. ELLIOT AH, Martling A, Glimelius B, Johansson H, et al
    Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer.
    Eur J Surg Oncol. 2016;42:1667-1673.
    PubMed     Text format     Abstract available
    
    
    
85. HASEGAWA S, Takahashi R, Hida K, Kawada K, et al
    Revisiting the treatment strategy for rectal cancer through the pattern of local recurrence.
    Eur J Surg Oncol. 2016;42:1674-1679.
    PubMed     Text format     Abstract available
    
    
    
86. ALAMRI Y, Buchwald P, Dixon L, Dobbs B, et al
    Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2016;42:1687-1692.
    PubMed     Text format     Abstract available
    
    
    October 2016
87. GHANIPOUR L, Jirstrom K, Sundstrom M, Glimelius B, et al
    Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 31. pii: S0748-7983(16)30951.
    PubMed     Text format     Abstract available
    
    
    
88. LEUNG V, Huo YR, Liauw W, Morris DL, et al
    Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
    Eur J Surg Oncol. 2016 Oct 13. pii: S0748-7983(16)30929.
    PubMed     Text format     Abstract available
    
    
    
89. LORIMIER G, Linot B, Paillocher N, Dupoiron D, et al
    Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 7. pii: S0748-7983(16)30899.
    PubMed     Text format     Abstract available
    
    
    
90. MACIVER AH, Lee N, Skitzki JJ, Boland PM, et al
    Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms.
    Eur J Surg Oncol. 2016 Oct 3. pii: S0748-7983(16)30901.
    PubMed     Text format     Abstract available
    
    
    September 2016
91. KRISHNAMURTHY A, Kankesan J, Wei X, Nanji S, et al
    Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30888.
    PubMed     Text format     Abstract available
    
    
    August 2016
92. WIELDRAAIJER T, Duineveld LA, van Asselt KM, van Geloven AA, et al
    Follow-up of colon cancer patients; causes of distress and need for supportive care: Results from the ICARE Cohort Study.
    Eur J Surg Oncol. 2016 Aug 31. pii: S0748-7983(16)30856.
    PubMed     Text format     Abstract available
    
    
    
93. JONES RP, Malik HZ, Fenwick SW, Terlizzo M, et al
    PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Eur J Surg Oncol. 2016 Aug 10. pii: S0748-7983(16)30837.
    PubMed     Text format     Abstract available
    
    
    July 2016
94. KENNELLY RP, Gryfe R, Winter DC
    Familial colorectal cancer: Patient assessment, surveillance and surgical management.
    Eur J Surg Oncol. 2016 Jul 27. pii: S0748-7983(16)30675.
    PubMed     Text format     Abstract available
    
    
    June 2016
95. MARGADANT CC, Bruns ER, Sloothaak DA, van Duijvendijk P, et al
    Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30592.
    PubMed     Text format     Abstract available
    
    
    
96. KOHNE CH, Poston G, Folprecht G, Ciardiello F, et al
    FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30587.
    PubMed     Text format     Abstract available
    
    
    
97. MOHAN HM, Ryan E, Balasubramanian I, Kennelly R, et al
    Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Eur J Surg Oncol. 2016 Jun 22. pii: S0748-7983(16)30164.
    PubMed     Text format     Abstract available
    
    
    
98. CHOLANKERIL G, Hu M, Tanner E, Cholankeril R, et al
    Skilled nursing facility placement in hospitalized elderly patients with colon cancer.
    Eur J Surg Oncol. 2016 Jun 17. pii: S0748-7983(16)30199.
    PubMed     Text format     Abstract available
    
    
    
99. REIMA H, Saar H, Innos K, Soplepmann J, et al
    Methylene blue intra-arterial staining of resected colorectal cancer specimens improves accuracy of nodal staging: A randomized controlled trial.
    Eur J Surg Oncol. 2016 Jun 16. pii: S0748-7983(16)30187.
    PubMed     Text format     Abstract available
    
    
    May 2016
100. RIBEIRO GOMES J, Belotto M, D'Alpino Peixoto R
     The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature.
     Eur J Surg Oncol. 2016 May 30. pii: S0748-7983(16)30170.
     PubMed     Text format     Abstract available
     
     
     
101. PIEGELER T, Beck-Schimmer B
     Anesthesia and colorectal cancer - The perioperative period as a window of opportunity?
     Eur J Surg Oncol. 2016 May 24. pii: S0748-7983(16)30154.
     PubMed     Text format     Abstract available
     
     
     
102. MONTRONI I, Wexner SD
     Robotic colorectal cancer surgery: Are data supporting the desire to innovate?
     Eur J Surg Oncol. 2016 May 21. pii: S0748-7983(16)30152.
     PubMed     Text format    
     
     
     
103. MARTINS J, Alexandrino H, Oliveira R, Cipriano MA, et al
     Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
     Eur J Surg Oncol. 2016;42:713-21.
     PubMed     Text format     Abstract available
     
     
     April 2016
104. GERVAZ P, Usel M, Rapiti E, Chappuis P, et al
     Right colon cancer: Left behind.
     Eur J Surg Oncol. 2016 Apr 23. pii: S0748-7983(16)30057.
     PubMed     Text format     Abstract available
     
     
     
105. THILLAI K, Repana D, Korantzis I, Kane P, et al
     Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment.
     Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30049.
     PubMed     Text format     Abstract available
     
     
     
106. PEDZIWIATR M, Pisarska M, Major P, Grochowska A, et al
     Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes.
     Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30055.
     PubMed     Text format     Abstract available
     
     
     
107. VAN AMERONGEN MJ, van der Stok EP, Futterer JJ, Jenniskens SF, et al
     Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
     Eur J Surg Oncol. 2016;42:523-30.
     PubMed     Text format     Abstract available
     
     
     
108. LYKKE J, Jess P, Roikjaer O
     The prognostic value of lymph node ratio in a national cohort of rectal cancer patients.
     Eur J Surg Oncol. 2016;42:504-12.
     PubMed     Text format     Abstract available
     
     
     
109. BJORNSSON B, Sparrelid E, Rosok B, Pomianowska E, et al
     Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
     Eur J Surg Oncol. 2016;42:531-7.
     PubMed     Text format     Abstract available
     
     
     March 2016
110. WIGGANS MG, Shahtahmassebi G, Aroori S, Bowles MJ, et al
     The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
     Eur J Surg Oncol. 2016;42:426-32.
     PubMed     Text format     Abstract available
     
     
     February 2016
111. TANIS E, Spliethoff JW, Evers DJ, Langhout GC, et al
     Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.
     Eur J Surg Oncol. 2016;42:251-9.
     PubMed     Text format     Abstract available
     
     
     
112. GHIGNONE F, van Leeuwen BL, Montroni I, Huisman MG, et al
     The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons' attitudes.
     Eur J Surg Oncol. 2016;42:297-302.
     PubMed     Text format     Abstract available
     
     
     
113. LLADO L, Munoz A, Ramos E, Torras J, et al
     The anterior hanging-approach improves postoperative course after right hepatectomy in patients with colorectal liver metastases. Results of a prospective study with propensity-score matching comparison.
     Eur J Surg Oncol. 2016;42:176-83.
     PubMed     Text format     Abstract available
     
     
     
114. TAKATSUKI M, Tokunaga S, Uchida S, Sakoda M, et al
     Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
     Eur J Surg Oncol. 2016;42:184-9.
     PubMed     Text format     Abstract available
     
     
     
115. VERMEER TA, Orsini RG, Nieuwenhuijzen GA, Rutten HJ, et al
     Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline.
     Eur J Surg Oncol. 2016;42:273-80.
     PubMed     Text format     Abstract available
     
     
     
116. RUPINSKI M, Szczepkowski M, Malinowska M, Mroz A, et al
     Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
     Eur J Surg Oncol. 2016;42:288-96.
     PubMed     Text format     Abstract available
     
     
     
117. KUIJPERS AM, Hauptmann M, Aalbers AG, Nienhuijs SW, et al
     Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
     Eur J Surg Oncol. 2016;42:244-50.
     PubMed     Text format     Abstract available
     
     
     
118. BOUHADJARI N, Gabato W, Calabrese D, Msika S, et al
     Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
     Eur J Surg Oncol. 2016;42:219-23.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: